GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Gata1 | rn6_v1_chrX_+_15378789_15378789 | 0.50 | 1.1e-21 | Click! |
Gata2 | rn6_v1_chr4_+_120133713_120133713 | 0.00 | 9.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_119225040 Show fit | 146.91 |
ENSRNOT00000012365
|
bone morphogenetic protein 10 |
|
chr4_+_57952982 Show fit | 135.57 |
ENSRNOT00000014465
|
carboxypeptidase A1 |
|
chr1_+_279798187 Show fit | 133.38 |
ENSRNOT00000024065
|
pancreatic lipase |
|
chr12_-_46889082 Show fit | 121.41 |
ENSRNOT00000001525
|
phospholipase A2 group IB |
|
chr14_+_26662965 Show fit | 120.68 |
ENSRNOT00000002621
|
trans-2,3-enoyl-CoA reductase-like |
|
chr5_-_155772040 Show fit | 110.46 |
ENSRNOT00000036788
|
chymotrypsin-like elastase family, member 3B |
|
chr4_+_70614524 Show fit | 98.01 |
ENSRNOT00000041100
|
protease, serine 3 |
|
chr1_+_72882806 Show fit | 97.34 |
ENSRNOT00000024640
|
troponin I3, cardiac type |
|
chr3_+_79940561 Show fit | 94.09 |
ENSRNOT00000016652
|
myosin binding protein C, cardiac |
|
chr6_-_26385761 Show fit | 73.70 |
ENSRNOT00000073228
|
glucokinase regulator |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
35.8 | 179.0 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
14.8 | 133.4 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
8.2 | 130.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
40.5 | 121.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
7.1 | 120.7 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 111.4 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
9.4 | 94.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.7 | 90.8 | GO:0031638 | zymogen activation(GO:0031638) |
7.7 | 84.5 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.8 | 79.8 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 1006.0 | GO:0005615 | extracellular space(GO:0005615) |
1.2 | 169.1 | GO:0030018 | Z disc(GO:0030018) |
24.3 | 97.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
15.7 | 94.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 61.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.5 | 61.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.7 | 60.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
11.6 | 57.9 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.0 | 56.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.4 | 51.0 | GO:0042383 | sarcolemma(GO:0042383) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 319.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
6.5 | 176.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
21.0 | 146.9 | GO:0031433 | telethonin binding(GO:0031433) |
1.5 | 134.9 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
6.7 | 133.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
13.5 | 121.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
2.3 | 120.7 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
24.3 | 97.3 | GO:0030172 | troponin C binding(GO:0030172) |
8.6 | 94.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
5.6 | 77.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 338.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 130.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
1.7 | 121.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
2.8 | 66.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 59.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.1 | 59.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.8 | 57.6 | PID EPO PATHWAY | EPO signaling pathway |
0.6 | 55.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.5 | 47.0 | PID ALK1 PATHWAY | ALK1 signaling events |
1.7 | 44.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 272.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
7.6 | 121.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
2.9 | 112.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
5.0 | 84.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
2.5 | 73.7 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
6.8 | 61.0 | REACTOME DEFENSINS | Genes involved in Defensins |
3.0 | 54.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.4 | 51.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.8 | 39.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 37.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |